QUAKER CHEMICAL CORP (KWR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 700M 1.4B 2.1B Q3 '21: 1.7B Q4 '21: 1.8B Q1 '22: 1.8B Q2 '22: 1.9B Q3 '22: 1.9B Q4 '22: 1.9B Q1 '23: 2B Q2 '23: 2B Q3 '23: 2B Q4 '23: 2B Q1 '24: 1.9B Q2 '24: 1.9B Q3 '24: 1.9B Q4 '24: 1.8B Q1 '25: 1.8B Q2 '25: 1.8B Q3 '25: 1.9B Q4 '25: 1.9B Q1 '26: 1.9B Q2 '26: 2B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 250M 500M 750M Q3 '21: 597.8M Q4 '21: 594.6M Q1 '22: 584.5M Q2 '22: 579.6M Q3 '22: 595.2M Q4 '22: 612.7M Q1 '23: 640M Q2 '23: 668.2M Q3 '23: 690.8M Q4 '23: 705.6M Q1 '24: 713.8M Q2 '24: 711.8M Q3 '24: 701M Q4 '24: 686M Q1 '25: 665.7M Q2 '25: 661.7M Q3 '25: 670M Q4 '25: 679.4M Q1 '26: 694.8M Q2 '26: 712.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

0 80M 160M 240M Q3 '20: 44.9M Q4 '20: 59.4M Q1 '21: 116.7M Q2 '21: 153.3M Q3 '21: 154.4M Q4 '21: 150.5M Q1 '22: 135M Q2 '22: 128.1M Q3 '22: 136.7M Q4 '23: 214.5M Q1 '24: 220.1M Q2 '24: 221.7M Q3 '24: 213.9M Q4 '24: 194.7M Q1 '25: 166.8M Q2 '25: 55.8M Q3 '25: 50.8M Q4 '25: 53M Q1 '26: 59M Q2 '26: 152.1M Q4 '20 Q3 '21 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-60M 0 60M 120M 180M Q3 '20: 6.4M Q4 '20: 39.7M Q1 '21: 106.7M Q2 '21: 148M Q3 '21: 151.7M Q4 '21: 121.4M Q1 '22: 102.6M Q2 '22: 83.3M Q3 '22: 78.2M Q4 '23: 112.7M Q1 '24: 118.4M Q2 '24: 124M Q3 '24: 122.7M Q4 '24: 116.6M Q1 '25: 94.3M Q2 '25: -7.1M Q3 '25: -9M Q4 '25: -2.5M Q1 '26: 4.3M Q2 '26: 97.7M Q4 '20 Q3 '21 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 500M 1B 1.5B Q3 '21: 1.1B Q4 '21: 1.2B Q1 '22: 1.2B Q2 '22: 1.3B Q3 '22: 1.3B Q4 '22: 1.3B Q1 '23: 1.3B Q2 '23: 1.3B Q3 '23: 1.3B Q4 '23: 1.2B Q1 '24: 1.2B Q2 '24: 1.2B Q3 '24: 1.2B Q4 '24: 1.2B Q1 '25: 1.1B Q2 '25: 1.2B Q3 '25: 1.2B Q4 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.3B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 100M 200M 300M Q3 '21: 68.8M Q4 '21: 48.9M Q1 '22: 55.3M Q2 '22: 50.1M Q3 '22: 20.1M Q4 '22: 41.8M Q1 '23: 85.9M Q2 '23: 166.3M Q3 '23: 267.5M Q4 '23: 279M Q1 '24: 268.5M Q2 '24: 236.5M Q3 '24: 221.1M Q4 '24: 204.6M Q1 '25: 174.3M Q2 '25: 169.6M Q3 '25: 153M Q4 '25: 136.5M Q1 '26: 143.3M Q2 '26: 131.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-90M 0 90M 180M 270M Q3 '21: 50.3M Q4 '21: 27.5M Q1 '22: 28.9M Q2 '22: 20.5M Q3 '22: -8.7M Q4 '22: 13.3M Q1 '23: 60M Q2 '23: 135.8M Q3 '23: 233.4M Q4 '23: 240.2M Q1 '24: 231.4M Q2 '24: 203.6M Q3 '24: 188.7M Q4 '24: 162.8M Q1 '25: 124.6M Q2 '25: 118.6M Q3 '25: 96.9M Q4 '25: 80.6M Q1 '26: 89.1M Q2 '26: 74.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 7M 14M 21M Q1 '20: 17.7M Q2 '20: 17.7M Q3 '20: 17.8M Q1 '21: 17.9M Q2 '21: 17.8M Q3 '21: 17.9M Q1 '22: 17.9M Q2 '22: 17.8M Q3 '22: 17.9M Q1 '23: 17.9M Q2 '23: 17.9M Q3 '23: 17.9M Q1 '24: 17.9M Q2 '24: 17.9M Q3 '24: 17.9M Q1 '25: 17.7M Q2 '25: 17.6M Q3 '25: 17.4M Q1 '26: 17.4M Q2 '26: 17.2M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 0.00 3.00 6.00 9.00 Q3 '20: 0.36 Q4 '20: 2.22 Q1 '21: 5.97 Q2 '21: 8.28 Q3 '21: 8.48 Q4 '21: 6.77 Q1 '22: 5.73 Q2 '22: 4.65 Q3 '22: 4.36 Q4 '23: 6.26 Q1 '24: 6.57 Q2 '24: 6.88 Q3 '24: 6.82 Q4 '24: 6.51 Q1 '25: 5.29 Q2 '25: -0.43 Q3 '25: -0.49 Q4 '25: -0.14 Q1 '26: 0.26 Q2 '26: 5.59 Q4 '20 Q3 '21 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.